journal article·2024-07-31

DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury

Yu Fan, Chengshi Wang, Wenshu Dai, Yaojia Zhou, Gonggong Lu, Wei Li, Ling Li, Tao Lin

ACS Applied Materials & Interfaces· Volume 16· Issue 30
Publisher page

Abstract

Renal ischemia-reperfusion injury (IRI) is a major contributing factor to the development of acute kidney injury (AKI) and has resulted in considerable morbidity and mortality. Persistent inflammatory responses and excessive reactive oxygen species (ROS) in the kidney following IRI can severely delay tissue repair, making it challenging to effectively promote IRI regeneration. Herein, we report an approach to enhance immunotherapy using interleukin-10 (IL-10) to promote IRI regeneration by loading IL-10 onto rectangular DNA origami nanostructures (rDON). rDON can significantly enhance the renal accumulation and retention time of IL-10, enabling it to effectively polarize type 1 macrophages into type 2 macrophages, thereby significantly reducing proinflammatory factors and increasing anti-inflammatory factors. In addition, DNA origami helps mitigate the harmful effects of ROS during renal IRI. The administration of IL-10-loaded DNA origami effectively improves kidney function, resulting in a notable reduction in blood urea nitrogen, serum uric acid, and serum creatinine levels. Our study demonstrates that the integration of anti-inflammatory cytokines within DNA origami holds promise as a strategic approach for cytokine immunotherapy in patients with AKI and other renal disorders.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Acute Kidney Injury Research · Extracellular vesicles in disease · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology, Institute of Urology and Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China

NHC Key Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China

Animal Experimental Center, West China Hospital, Sichuan University, Chengdu 610041, China

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China

Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China

Funding

West China Hospital, Sichuan University · Natural Science Foundation of Sichuan Province · National Natural Science Foundation of China

References (41)

Show source-provided references
1. 10.1016/S0140-6736(19)32563-210.1016/S0140-6736(19)32563-2 ↗
2. 10.1016/S0140-6736(11)61454-210.1016/S0140-6736(11)61454-2 ↗
3. 10.1152/ajprenal.00195.201810.1152/ajprenal.00195.2018 ↗
4. 10.1038/s41551-018-0317-810.1038/s41551-018-0317-8 ↗
5. 10.1038/ki.2013.15310.1038/ki.2013.153 ↗
6. 10.1016/j.pharmthera.2019.04.00110.1016/j.pharmthera.2019.04.001 ↗
7. 10.1038/s41467-020-17205-510.1038/s41467-020-17205-5 ↗
8. 10.1681/ASN.201707077410.1681/ASN.2017070774 ↗
9. 10.1038/nrneph.2015.21410.1038/nrneph.2015.214 ↗
10. 10.1021/acs.nanolett.1c0104410.1021/acs.nanolett.1c01044 ↗
11. 10.1038/nm.250710.1038/nm.2507 ↗
12. 10.1172/JCI4516110.1172/JCI45161 ↗
13. 10.1681/ASN.201703024710.1681/ASN.2017030247 ↗
14. 10.1021/acsnano.1c0727010.1021/acsnano.1c07270 ↗
15. 10.1681/ASN.201704039810.1681/ASN.2017040398 ↗
16. 10.1681/ASN.201612127210.1681/ASN.2016121272 ↗
17. 10.1016/j.immuni.2019.03.02010.1016/j.immuni.2019.03.020 ↗
18. 10.1126/sciadv.aaz074810.1126/sciadv.aaz0748 ↗
19. 10.1021/acsami.2c0476910.1021/acsami.2c04769 ↗
20. 10.1046/j.1523-1755.2001.00043.x10.1046/j.1523-1755.2001.00043.x ↗
21. 10.1038/labinvest.2013.6410.1038/labinvest.2013.64 ↗
22. 10.1126/science.aal353510.1126/science.aal3535 ↗
23. 10.1039/D0BM01151G10.1039/D0BM01151G ↗
24. 10.1002/adhm.20230031110.1002/adhm.202300311 ↗
25. 10.1021/acsami.2c1649210.1021/acsami.2c16492 ↗
26. 10.1016/j.addr.2021.11409710.1016/j.addr.2021.114097 ↗
27. 10.1016/j.actbio.2024.01.03610.1016/j.actbio.2024.01.036 ↗
28. 10.1038/s41565-023-01471-710.1038/s41565-023-01471-7 ↗
29. 10.1038/s41565-024-01615-310.1038/s41565-024-01615-3 ↗
30. 10.1038/nbt.407110.1038/nbt.4071 ↗
31. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
32. 10.1038/s41563-024-01826-y10.1038/s41563-024-01826-y ↗
33. 10.1021/acsami.8b2172410.1021/acsami.8b21724 ↗
34. 10.1021/jacs.7b0932310.1021/jacs.7b09323 ↗
35. 10.1021/ja403863a10.1021/ja403863a ↗
36. 10.1021/acs.chemrev.3c0002810.1021/acs.chemrev.3c00028 ↗
37. 10.1038/s41467-019-13507-510.1038/s41467-019-13507-5 ↗
38. 10.1021/acsnano.3c1021310.1021/acsnano.3c10213 ↗
39. 10.1002/adma.20180478510.1002/adma.201804785 ↗
40. 10.1021/acsnano.2c0399110.1021/acsnano.2c03991 ↗
41. 10.1111/jcmm.1500510.1111/jcmm.15005 ↗